Related Experiment Video

Updated: Mar 16, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

9.0K

The Role of MicroRNAs in Myeloproliferative Neoplasia

Shaban Alizadeh1, Seyed Ghader Azizi1, Masoud Soleimani2

  • 1Hematology Department, School of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran.

International Journal of Hematology-Oncology and Stem Cell Research
|August 5, 2016
PubMed

Insights

MicroRNAs (miRs) play a key role in cancer development and can be therapeutic targets. This study evaluates miRs' role in myeloproliferative neoplasias (MPNs) pathogenesis and treatment, including drug resistance.

Area of Science:

  • Molecular Biology
  • Oncology
  • Hematology

Background:

  • MicroRNAs (miRs) are non-coding RNAs regulating gene expression, crucial in cancer development.
  • Myeloproliferative neoplasms (MPNs) are hematologic malignancies linked to genetic mutations like BCR-ABL and JAK2V617F.
  • Aberrant miR expression is implicated in MPN pathogenesis, progression, and treatment response.

Purpose of the Study:

  • To investigate the multifaceted role of miRs in the pathogenesis of MPNs.
  • To explore the potential of miRs as therapeutic targets and prognostic factors in MPN treatment.
  • To evaluate the impact of miRs on drug resistance, particularly to tyrosine kinase inhibitors like Imatinib in Chronic Myeloid Leukemia (CML).

Main Methods:

  • Literature review and analysis of existing studies on miRs in MPNs.
  • Examination of miR expression patterns in relation to MPN subtypes and clinical outcomes.
  • Assessment of the mechanisms by which miRs influence oncogenesis and drug resistance.

Main Results:

  • MiRs can act as tumor suppressors or oncogenes, influencing cancer development.
  • Altered miR expression is significantly associated with MPN development, progression, and treatment efficacy.
  • Specific miRs are involved in resistance to treatments like Imatinib, presenting a major clinical challenge.

Conclusions:

  • MiRs are critical players in MPN pathogenesis and represent promising therapeutic targets.
  • Understanding miR dysregulation can lead to improved prognostic markers and novel treatment strategies for MPNs.
  • Modulating miR expression holds potential for overcoming drug resistance and enhancing treatment outcomes in MPNs.
Keywords:
MicroRNAMyeloproliferative neoplasmsPathogenesis

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

481
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
MicroRNAs01:22

MicroRNAs

12.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.8K